Cleared Traditional

RANDOX LIQUID URINE CONTROL LEVELS 2 AND 3 (K110904) - FDA 510(k) Clearance

Class I Chemistry device.

K110904 · Randox Laboratories, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2011
Decision
183d
Days
Class 1
Risk

K110904 is an FDA 510(k) clearance for the RANDOX LIQUID URINE CONTROL LEVELS 2 AND 3. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Randox Laboratories, Ltd. (Crumlin, GB). The FDA issued a Cleared decision on September 30, 2011 after a review of 183 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Randox Laboratories, Ltd. devices

Submission Details

510(k) Number K110904 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2011
Decision Date September 30, 2011
Days to Decision 183 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
95d slower than avg
Panel avg: 88d · This submission: 183d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 672
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K110904.
ABBOTT ARCHITECH GLYCATED HEMOGLOBIN MASTERCHECK
K992710 · Abbott Laboratories · Nov 1999
DADE IAC-X COMPREHENSIVE IMMUNOASSAY CONTROL
K912455 · Baxter Healthcare Corp · Aug 1991
DADE LIID-TROL TL TRI-LEVEL LIPID CONTROL
K911854 · Baxter Healthcare Corp · Jun 1991
QCLYTE PROTEIN BASED ISE CONTROL
K904968 · Baxter Healthcare Corp · Dec 1990
DADE(R) CSF.L, LIQ CEREBROSPIN FLUID CTRL LEV 1&2
K903933 · Baxter Healthcare Corp · Oct 1990
DADE IMMUNOASSAY CONTROLS, LEVELS I, II, III
K903566 · Baxter Healthcare Corp · Sep 1990